Pioglitazone Therapy for Chronic Granulomatous Disease
Status:
Terminated
Trial end date:
2019-10-20
Target enrollment:
Participant gender:
Summary
The purpose of this proposed research is to investigate the efficacy and safety of the
therapy with pioglitazone for chronic granulomatous disease (CGD) patients severe infection.